Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 10, No. 5, 2000  

Free Abstract   Article (Fulltext)    Article (PDF 848 KB)     

Original Paper

Early 99mTc-Ethylcysteinate Dimer Brain SPECT Patterns in the Acute Phase of Stroke as Predictors of Neurological Recovery
Marie-Hélène Mahagnea, Jacques Darcourtc, Octave Mignecoc, Jean-Paul Fourniera, Didier Thiercelina, Sylvie Ducœura, François Bertranda, Françoise Bussièrec, Marcel Chatelb, Jean-Claude Barond

aEmergency Department and
bDepartment of Neurology, University of Nice,
cDepartment of Nuclear Medicine, Centre Antoine-Lacassagne, Biophysics and Image Processing, University of Nice, Sophia Antipolis, and
dInstitut National de la Santé et de la Recherche Médicale U 320, Centre Cycéron, Caen, France

Address of Corresponding Author

Cerebrovasc Dis 2000;10:364-373 (DOI: 10.1159/000016092)


 goto top of page Key Words

  • Acute stroke
  • Single-photon emission computed tomography
  • Ethylcysteinate dimer

 goto top of page Abstract

Objectives: Accurate prediction of outcome in acute stroke would help in identifying subgroups of patients for therapeutic trials and intravenous thrombolysis. The purpose of this study was to prospectively test the hypothesis that brain SPECT, with 99mTc-L,L-ethylcysteinate dimer (ECD), a tracer sensitive to cell function, performed in the first hours after stroke onset, adds predictive power to concomitant neurological evaluation. Methods: Twenty-four patients with a first-ever middle cerebral artery stroke were prospectively studied with ECD-SPECT within 12 h after stroke onset. Neurological evaluation was performed using Orgogozo’s scale at admission and 3 months later in order to calculate the percent Martinez-Vila evolution indices (EI%). Semiquantitative visual analysis of SPECT images was performed in 6 cortical regions relevant for carotid artery territory. Both the extent and the intensity of cortical reduced ECD uptake were calculated, leading to an ‘ischemia’ score, corresponding to the sum of regions of interest (ROI) where ECD uptake was between 40 and 80% of the contralateral healthy hemisphere, and an ‘irreversibly damaged tissue’ (IDT) score, corresponding to an uptake below 40%, and a total score (ischemia + IDT). Each patient was assigned to one of three patterns: (1) pattern I with severe ECD cortical uptake reduction defined by at least one ROI with uptake under 40%, (2) pattern II with moderate ECD cortical uptake reduction (40–80%) only and (3) pattern III with normal ECD uptake. Results: There were 11 patients (46%) with pattern I ECD-SPECT. This group had almost invariably (10/11 patients) a poor outcome. The 12 patients (50%) classified in pattern II had a variable clinical outcome, ranging from improvement to deterioration. The single patient with a normal SPECT (pattern III) had a full clinical recovery. Both total score and IDT score were strongly significantly correlated with neurological recovery EI% (respectively p = 0.006 and 0.004). Their predictive value was significantly higher than, and independent of, day 0 neurological evaluation. No patient had an increased ECD uptake. Conclusion: Our results show that the degree of ECD cortical uptake reduction, measured on early brain SPECT, is a strong predictor of neurological recovery. ECD-SPECT data have a higher predictive value than day 0 neurological evaluation. The apparently better predictive value of ECD over hexamethylpropyleneamine oxime may reflect this tracer’s brain retention mechanisms which are weighted more towards cell function than towards perfusion. ECD-SPECT is easily obtainable and may help in selecting out from therapy those patients who are likely to have either very good or very poor spontaneous outcome, and thus improve the assessment of acute stroke and the choice of therapeutic strategy.

Copyright © 2000 S. Karger AG, Basel


 goto top of page Author Contacts

Marie-Hélène Mahagne, MD
Emergency Department, Hôpital Saint-Roch
5, rue Pierre-Dévoluy, BP 1319
F–06006 Nice Cedex 1 (France)
Tel. +33 4 92 03 33 89, Fax +33 4 92 03 33 87


 goto top of page Article Information

Received: Received: July 25, 1999
Accepted: December 3, 1999
Number of Print Pages : 10
Number of Figures : 3, Number of Tables : 2, Number of References : 48

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
PubMed ID 10971022
Download Citation



This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Neurology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2010 S. Karger AG, Basel